中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Combination Immunotherapy with Cytotoxic T-Lymphocyte-Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 3, 页码: 802-811
作者:  Sun, Ting;  Zhang, Wenjia;  Li, Yuan;  Jin, Zhengyu;  Du, Yang;  Tian, Jie;  Xue, Huadan
收藏  |  浏览/下载：233/0  |  提交时间：2020/04/07
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 15
作者:  Xiong, Kai;  Zhang, Hejun;  Du, Yang;  Tian, Jie;  Ding, Shigang
收藏  |  浏览/下载：202/0  |  提交时间：2019/12/16
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载：422/102  |  提交时间：2019/12/16
Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging 期刊论文
CANCER LETTERS, 2019, 卷号: 453, 页码: 74-83
作者:  Liu, Shengnan;  Du, Yang;  Ma, He;  Liang, Qian;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载：243/0  |  提交时间：2019/07/12
Hepatocellular carcinoma  Regorafenib  Sorafenib  Molecular imaging  Therapeutic effects